Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1472)	2/17/2003 5:19:55 AM
From: nigel bates	of 3158

Never held any, but liked the concept. Now if Fluidigm were public... Meanwhile - LONDON, Feb 17 (Reuters) - Struggling British biotechnology company ReNeuron Holdings Plc, Europe's first listed stem cell company, said on Monday it had received a bid approach and was in discussions that could lead to an offer. The company gave no further details in a brief statement but one industry source told Reuters the potential bidder was a private British concern. The source said media reports that unlisted UK cell therapy firm CellFactors or U.S.-based Geron Corp (NasdaqNM:GERN) were in talks were inaccurate. Shares in ReNeuron, which have plunged on concerns about its delayed clinical trial programme since the group floated on London's Alternative Investment Market in 2000, rose 1-1/2 pence, or 31 percent, to 5-3/4p by 0815 GMT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next